Research & Publications
I am a pediatric hematologist-oncologist and epidemiologist focused on improving outcomes in patients previously treated for childhood cancer.
Extensive Research Description
Dr. Kadan-Lottick's research seeks to reduce late complications and improve quality of life in pediatric and adult survivors of childhood cancer. She established the Yale HEROS Survivors’ Program in 2003 as one of the first of its kind in the United States. Prior to Yale, she completed a post-doctoral fellowship in cancer survivorship with Dr. Leslie Robison working on the NCI-funded ongoing Childhood Cancer Survivorship Cohort (CCSS). Dr. Kadan-Lottick is the current and past PI of multiple survivorship studies funded by the National Cancer Institute, the American Cancer Society, St. Baldrick’s Foundation, and the Hyundai Foundation. She is the chair of five current/past multi-site Children’s Oncology Group (COG) studies that measure physical, neuro-cognitive, psychological, and neurological outcomes in children with cancer. She has experience successfully coordinating different sites, achieving enrollment goals, and overcoming methodological issues. She is a member of the COG Survivorship Steering Committee, COG Acute Lymphoblastic Leukemia Committee, and serve as the Yale site PI for COG Consortium studies. Dr. Kadan-Lottick has built productive collaborations with co-investigators at Yale and around the world.
Health Services; Medical Oncology; Pediatrics; Quality of Life; Cancer Survivors